Terns Pharmaceuticals, Inc. (TERN)
36.19
-1.58
(-4.18%)
USD |
NASDAQ |
Jan 09, 13:11
Terns Pharmaceuticals Research and Development Expense (Annual): 70.11M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Altimmune, Inc. | 81.99M |
| Ligand Pharmaceuticals, Inc. | 21.42M |
| ADMA Biologics, Inc. | 1.813M |
| Viking Therapeutics, Inc. | 101.64M |
| Cidara Therapeutics, Inc. | 71.88M |